REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) › Operating Cash FlowREVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$218.4K2020: -$4.07M2021: -$10.67M2022: -$18.96M2023: -$28.32M2024: -$33.54M2025: -$24.59M-$24.59M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$24.59M+26.7%2024-$33.54M-18.4%2023-$28.32M-49.4%2022-$18.96M-77.7%2021-$10.67M-162.3%2020-$4.07M-1761.6%2019-$218.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share